Regeneron’s Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable.
Dr. Ajit Shetty has 36 years of pharmaceutical industry experience, first joining Janssen Pharmaceutica in 1976.
Tesaro’s Zejula is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response (CR or PR) to platinum-based chemotherapy.
Results showed a 6% increase over clinics that did not use the alert system, representing a 37% relative increase in vaccinations from the prior year.
Paul Bisaro previously served as executive chairman of Allergan, and president, CEO and chairman of the board of Actavis.
America is the largest generic drugs market in the world.
The Seller/Buyer Offering Plan will match the interests of potential buyers to the pharmacy with customized, focused marketing via PRS's extensive network of buyers and contacts.
Drug is intended for the treatment of pemphigus vulgaris, a painful, disfiguring and potentially fatal autoimmune disease characterized by progressive blistering of skin and/or mucous membranes.